Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|November 15, 2002
[The "needle man": more than 40,000 injections in 40 years]S Schiekofer, P Heilmann, P P Nawroth, et al.Seminars in Thrombosis and Hemostasis|December 29, 2000
Endothelial dysfunction in diabetes mellitusS Schiekofer, B Balletshofer, M Andrassy, et al.Diabetes, Obesity & Metabolism|August 22, 2006
Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetesS Schiekofer, G Galasso, M Andrassy, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 19, 2009
The proline 12 alanine substitution in the PPARgamma2 gene is associated with increased extent of coronary artery disease in menJ G Schneider, S Schiekofer, M von Eynatten, et al.Clinical and Experimental Immunology|October 7, 2015
Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-upF M Rasche, F Keller, W G Rasche, et al.Biofactors (Oxford, England)|December 28, 1999
The role of oxidative stress and NF-kappaB activation in late diabetic complicationsA K Mohamed, A Bierhaus, S Schiekofer, et al.Clinical and Experimental Immunology|June 11, 2016
Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?F M Rasche, F Keller, W G Rasche, et al.Thrombosis and Haemostasis|August 7, 2001
Tissue factor--a receptor involved in the control of cellular properties, including angiogenesisJ Chen, A Bierhaus, S Schiekofer, et al.Diabetes Research and Clinical Practice|April 27, 2001
Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory studyM Morcos, V Borcea, B Isermann, et al.Diabetes Care|August 14, 1998
Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetesM A Hofmann, S Schiekofer, M Kanitz, et al.Pageof 2